Ankit A. Mahadevia, M.D., M.B.A. (2016)
Ankit A. Mahadevia is a principal at Atlas Venture, a Cambridge, Mass.-based venture capital firm financing and building early-stage enterprises in the life sciences and technology. He focuses on early-stage biopharmaceutical and medical device companies.
Mahadevia currently serves on the board of RaNA Therapeutics, Annovation Biopharma, Lumavita AG and Fibrex Medical. He has worked closely on several novel alliances between Atlas Venture and the pharmaceutical/biotechnology industry, including on Atlas’ investment alliances with Shire and Monsanto and on Arteaus, an asset collaboration with Eli Lilly and Company. Mahadevia also serves on the board of the Johns Hopkins Alliance for Technology Transfer and helps organize the annual University Research and Entrepreneurship Symposium in Boston for emerging academic technologies, among other roles promoting translation of biomedical research by biotechnology companies.
Mahadevia completed his medical degree at the Johns Hopkins University School of Medicine and received his master’s degree in business administration from the Wharton School at the University of Pennsylvania.
Social Media Links